Dr. Chen specializes in neuromodulation therapies—transcranial magnetic stimulation (TMS), MR-guided focused ultrasound (MRgFUS), and botulinum toxin—for conditions such as Parkinson’s disease, dystonia, stroke, and dementia. The team leads the clinical application and academic development of MRgFUS for movement disorders, particularly Parkinson’s disease and essential tremor. We pioneered a stepwise dual-target strategy (PTT + VIM) to treat both tremor and rigidity with high precision and minimal invasiveness. Our research explores brain stimulation mechanisms, multimodal neuroimaging, and outcomes of non-invasive therapies. The team actively engages in international clinical trials and collaborations.